Mediaboss Marketing

REDDING, Calif., March 22, 2021 /PRNewswire/ -- Infectious disease diagnostic products comprise consumables, instruments, software & services used for the diagnosis of infectious diseases, such as influenza, tuberculosis, hepatitis, and others. Infectious disease diagnostics is an emerging market as it helps doctors and clinicians in early diagnosis, thereby offering appropriate treatment. Owing to the recent outbreak of coronavirus (COVID-19), this market is expected to expand in the upcoming years as more and more diagnostic test kits will be required for early diagnosis.

The infectious disease diagnostics market is expected to grow at a CAGR of 6.9% from 2020 to reach $42.85 billion by 2027. The growth of this market is mainly attributed to the increasing prevalence of infectious diseases, growing awareness for early disease diagnoses, increasing funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing. Moreover, the outbreak of the COVID19 pandemic will result in higher demand for infectious disease diagnostic products.

DownloadFree Sample Report Now @https://www.meticulousresearch.com/download-sample-report/cp_id=4976

The global infectious disease diagnostics market is segmented on the basis of product & service, technology, disease type, end user, and geography.

Based on product & service, the infectious disease diagnostics market is segmented into consumables, instruments, and software & services. In 2020, the consumables segment accounted for the largest share of the overall infectious disease diagnostics market. The large share of this segment is primarily attributed to the commercial availability of a diverse range of reagents & consumables for various diseases diagnosis and their recurrent expense. In addition, the outbreak of COVID-19 is expected to accelerate the growth of this segment, owing to the requirement of various kits and assays.

Based on technology, the infectious disease diagnostics market is broadly segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & next-generation sequencing (NGS), DNA microarray, and other technologies (microscopy, hybridization, and loop-mediated isothermal amplification). In 2020, the immunodiagnostics segment accounted for the largest share of the overall infectious disease diagnostics market. The large share of this segment is primarily attributed to the emergence of advanced diagnostic immunoassay formats, increasing usage of miniaturized devices, and rising trend for automation in immunoassay instruments.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:https://www.meticulousresearch.com/speak-to-analyst/cp_id=4976

Based on disease type, the infectious disease diagnostics market is broadly segmented into hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIs), human papillomavirus (HPV), tuberculosis (TB), influenza, and other diseases (measles, mumps, typhoid fever, malaria, meningitis, Ebola, and COVID-19, among others). In 2020, the hepatitis segment accounted for the largest share of the overall infectious disease diagnostics market. The large share of this segment is primarily attributed to the rising prevalence of hepatitis cases and increasing initiatives by government organizations towards hepatitis prevention.

Based on end user, the infectious disease diagnostics market is broadly segmented into hospital & clinical laboratories, diagnostic reference laboratories, academics/research institutes, and other end users (nursing facilities and home care facilities). In 2020, the diagnostic reference laboratories segment accounted for the largest share of the overall infectious disease diagnostics market. The large share of this segment is primarily attributed to the rising laboratory automation, availability of well-equipped systems, presence of skilled labors, rise in the number of the patient volume owing to the emergence of various infectious diseases, and government initiatives to support the technological advancements of laboratories.

Based on geography, the global infectious disease diagnostics market is categorized into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with a further analysis of major countries in these regions. In 2020, North America accounted for the largest share of the global infectious disease diagnostics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The growing healthcare sector, increasing healthcare expenditure, growing demand for point-of-care testing, and increase in the research and development coupled with the development of novel advanced technologies for diagnosis are the major factors driving the growth of the North American market.

Quick Buy Infectious Disease Diagnostics Market Research Report:https://www.meticulousresearch.com/Checkout/65879068

Some of the key players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMrieux S.A. (France), Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), and Quidel Corporation (U.S.) among others.

To gain more insights into the market with a detailed table of content and figures, click here:https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976

Scope of the Report:

Infectious Disease DiagnosticsMarket by Product & Solution

Infectious Disease DiagnosticsMarket by Technology

Infectious Disease DiagnosticsMarket by Disease Type

Infectious Disease DiagnosticsMarket by End User

Infectious Disease DiagnosticsMarket by Geography

DownloadFree Sample Report Now @https://www.meticulousresearch.com/download-sample-report/cp_id=4976

Amidst this crisis, Meticulous Researchis continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-https://www.meticulousresearch.com/custom-research

Related Reports-

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) - Global Forecast to 2027

https://www.meticulousresearch.com/product/in-vitro-diagnostic-reagents-market-5110

Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes) - Global Forecast to 2027

https://www.meticulousresearch.com/product/influenza-diagnostics-market-5099

Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027

https://www.meticulousresearch.com/product/point-of-care-molecular-diagnostics-market-5081

COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025

https://www.meticulousresearch.com/product/COVID-19-impact-assessment-health-and-life-sciences-industry-5098

About Meticulous Research

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:

Mr.Khushal BombeMeticulous Market Research Inc.1267WillisSt,Ste200 Redding,California,96001, U.S.USA: +1-646-781-8004Europe : +44-203-868-8738APAC: +91 744-7780008Email-[emailprotected] Visit Our Website:https://www.meticulousresearch.com/ Connect with us on LinkedIn-https://www.linkedin.com/company/meticulous-research Content Source:https://www.meticulousresearch.com/pressrelease/55/infectious-disease-diagnostics-market-2027

SOURCE Meticulous Market Research Pvt. Ltd

Continue reading here:
Infectious Disease Diagnostics Market to Reach $42.85 Billion by 2027, Growing at a CAGR of 6.9% from 2020 with COVID-19 Impact - Meticulous Research...